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Introduction  
Listeria monocytogenes causes listeriosis in humans and animals, and 
is predominantly transmitted by ingestion of  contaminated food. 
This microorganism can also be transmitted transplacentally from 
mother to child, during passage through the colonized birth canal, 
or after direct contact with infected animals. The major groups 
at risk of  invasive listeriosis include pregnant women, neonates, 
elderly people and immunocompromised individuals. Clinical 
manifestations such as neonatal infections, abortions, bacteremia, 
meningitis and rhombencephalitis have been the most severe in-
fections [1, 2]. Listeriosis is one of  the most relevant foodborne 
diseases with an elevated socio-economical impact due to severity 
of  invasive infections associated with a high mortality rate [3]. 
Listeria spp. are widely distributed in the environment and differ-
ent foods, including dairy products. Recently, several outbreaks of  
listeriosis associated to consumption of  dairy products have been 
reported worldwide [4]. L. monocytogenes represents an important 
concern for food safety due to its ability to resist extreme condi-
tions (low pH, high salt concentrations and refrigeration tempera-
tures) which are commonly used as preservation procedures and 
thus may survive in food for long periods of  time [2, 5]. Other 
listerial species, such as L. ivanovii, L. seeligeri, L. welshimeri and L. 
innocua, have been reported to cause infections in humans. Some 
of  these species have been associated with bacteremia, acute men-
ingitis, coagulation disorders, and multiple-organ dysfunction, 
leading to the death of  the patients [6].
Although listeriosis is a notifiable disease in many developed 
countries, there has not been a reduction in its incidence [7, 8]. 
During the last years, the rate of  L. monocytogenes infection has 
varied between 0.29 and 1.8 cases per 100,000 inhabitants [9, 10]. 
For this reason, other strategies of  sanitary control against L. 
monocytogenes are being investigated. The application of  lactobacilli 
exhibits a promising approach for the control of  pathogenic mi-
croorganisms in both, the food industry as well as the biomedical 
field. The biocontrol exerted by Lactobacillus spp. is mainly due to 
the production of  antimicrobial substances such as organic acids, 
hydrogen peroxide and bacteriocins [5, 11-13]. Bacteriocins are 
defined as proteinaceous antimicrobial substances, produced by 
bacteria that inhibit growth of  related or unrelated bacterial spe-
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cies. Bacteriocin-like inhibitory substance (BLIS) is an acronym 
used to refer to those bacteriocins whose amino-acid sequences 
have not yet been elucidated [13]. Our research group has identi-
fied and characterized two lactobacilli strains, Lactobacillus fermen-
tum L23 and Lactobacillus rhamnosus L60, which were selected for 
their bacteriocinogenic and probiotic properties. Furthermore, 
extensive investigations have demonstrated the ability of  these 
strains to inhibit the growth of  several pathogenic microorgan-
isms[13-18]. Currently, researchers have become increasingly in-
terested in the search for natural antimicrobial substances, such 
as bacteriocins, to develop biotechnological products for food in-
dustry applications as alternative to reduce chemical and thermal 
preservation methods [11, 19].
The aims of  this work were (1) to investigate the presence of  
Listeria spp. in raw cow milk and (2) to determine the inhibitory 
activity of  BLIS-es produced by Lactobacillus fermentum L23 and 
Lactobacillus rhamnosus L60 on L. monocytogenes and other listerial 
species isolated from food and clinical samples.
Materials and Methods
Isolation and identification of  Listeria spp.
Raw milk samples were collected between August 2012 and April 
2014 from Villa María, Córdoba. 814 samples from different 
quarters of  the mammary gland of  238 cows were analyzed for 
the presence of  Listeria spp.
The isolation of  Listeria spp. from milk samples was performed 
by means of  the double enrichment method followed by a plate 
isolation procedure. The first selective enrichment of  Listeria spp. 
was done in tryptic soy broth (TSB) (Britania, Argentina) added 
with ceftazidime (0.002% w/v) and trypaflavine neutral (0.25% 
w/v). Cultures were incubated for 48 h at 37°C. The enrichment 
broths were kept at 4°C for 48 h as a second selective enrichment. 
Each culture broth was seeded on Oxford agar plates (Britania, 
Argentina) and incubated at 37°C for 24-48 h. Typical colonies 
were identified by biochemical tests [20]. Other L. monocytogenes 
strains previously isolated from food and clinical samples were 
provided by the Bacteriology laboratory of  Universidad Nacional 
de Río Cuarto, Argentina. They were seeded on tryptic soy agar 
(TSA) plates (Britania, Argentina) and incubated at 37°C for 24 h. 
Strains were stored at -80°C in TSB containing 30% (v/v) glyc-
erol. All Listeria spp. from different origins were used as indicator 
microorganisms to evaluate the antimicrobial activity of  the bio-
active substances produced by L. fermentum L23 and L. rhamnosus 
L60.
Lactobacilli and culture media condition
Two human Lactobacillus strains, L. fermentum L23 and L. rhamnosus 
L60, were previously identified by standard biochemical tests, the 
API 50 CHL system (BioM`erieux, Inc., France) and 16S rRNA 
analysis. The 16S rRNA sequences of  both lactobacilli were de-
posited in the GenBank under the accession numbers GQ 455406 
and EF 495247 to L. fermentum L23 and L. rhamnosus L60, respec-
tively [18]. Lactobacilli strains were grown in De Man Rogosa 
Sharpe (MRS) broth or agar (Britania, Argentina) at 37°C under a 
5% CO2 atmosphere for 24 h. They were stored at -80°C in MRS 
broth containing 30% (v/v) glycerol.
Both Lactobacillus strains produce different antimicrobial com-
pounds such as organic acids, bacteriocins and, in the case of  L. 
rhamnosus L60, also hydrogen peroxide. The BLIS-es L23 and L60 
were previously purified by at least three-step procedure devel-
oped for class II bacteriocins [14-16].
Test of  antimicrobial activity
The antilisterial activity of  L. fermentum L23 and L. rhamnosus L60 
was tested by the streak diffusion method described by Asurmen-
di et al. [12]. On the other hand, the inhibitory activity of  cell 
free supernatant (CFS) and treated or neutralized CFS (NCFS), 
containing the BLIS-es L23 or L60, was evaluated against Listeria 
spp. strains by well diffusion test, on agar plates [18]. L. fermentum 
L23 and L. rhamnosus L60 were cultured in MRS broth and incu-
bated at 37°C under a 5% CO2 atmosphere for 20h. Then, the 
supernatants were removed by centrifugation (4,000xg at 4°C for 
20 min). These fractions with biological activity were neutralized 
with NaOH 1 mol ml-1 to eliminate the inhibitory effects of  the 
organic acids. TSA plates were seeded with a Listeria spp. culture 
(1.5 x 108 CFU ml-1) and wells were made into agar plates. 100 µl 
of  CFS and NCFS from each Lactobacillus strain were added to 
different wells. Plates were incubated for 24 h at 37°C and inhibi-
tion halos were measured.
Minimum inhibitory concentration of  the bacteriocin like 
inhibitory substances on the listerial growth
The minimum inhibitory concentration (MIC) values of  each 
BLIS, L23 and L60, were evaluated using a modification of  the 
well diffusion test on agar plates [16]. To obtain the BLIS L23, the 
CFS of L. fermentum L23 was neutralized with NaOH 1 mol ml-1. 
In the case of  BLIS L60, the NCFS of  L. rhamnosus L60 was also 
treated with 0.1 mg ml-1 peroxidase (Sigma) to eliminate the in-
hibitory effects attributed to the hydrogen peroxide. A suspension 
of  Listeria spp. in TSB broth (1.5 x 108 CFU ml-1) was seeded on 
TSA plates. 100 µl of  two fold serial dilutions of  each BLIS were 
spotted on different agar wells and plates were incubated. MIC of  
both BLIS-es was defined as the reciprocal of  the highest dilution 
which produced complete inhibition of  the indicator growth, and 
was expressed as activity units per milliliter (AU ml-1) [21].
Statistical Analysis
All tests were performed in triplicate, and mean ± SD were ex-
pressed. Differences in inhibitory activities between bacteriocin 
producing strains and their different bioactive supernatants were 
analyzed by ANOVA (P<0.05) using InfoStat Software. A P value 
of  <0.05 was considered statistically significant.
Results and Discussion
In the present study, a total of  814 raw milk samples from 238 
cows were examined for the presence of  Listeria spp. Two sam-
ples, obtained from different cows, were positive for Listeria spp. 
The listerial prevalence percentage in cattle was 0.84%. According 
to the biochemical identification, the isolates were identified as L. 
innocua (LI1) and L. welshimeri (LW1). Our results agreed with a 
previous report by Aygun and Pehlivanlar [22], who found a low 
prevalence value in raw cow milk. In contrast, a significantly high-
er listerial prevalence has been reported in the US (23%) and Iran 
(22.5%) during the last years [4, 23]. The listerial species isolated 
in this work coincided with recent works reported by Jamali et al. 
[4] and Rahimi et al. [24] who recovered L. innocua and L. welshimeri 
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among other listerial species.
Bacteria that belong to Listeria genus are indirect indicators of  
the potential presence of  L. monocytogenes in food because all lis-
terial species occur in similar environmental niches [25]. Since 
L. innocua and L. welshimeri have been reported to cause infec-
tions in humans, the presence of  these Listeria spp. found in this 
work, would consequently imply that the consumption of  raw 
or improperly pasteurized milk could represent a potential risk 
for human health. Moreover, the main causes of  contamination 
for these bacteria in raw milk are associated with fecal and en-
vironmental sources. Such contaminations could occur during 
milking, storage or transport, or directly from infected animals in 
dairy farms [26]. Since the listerial species isolated in the present 
study are non-pathogenic for cows, we suggest that the presence 
of  these microorganisms could be associated to environmental 
contaminations during milking practices, which are related with 
a poor hygienic quality of  milk. In Argentina, the information 
about the prevalence of  L. monocytogenes and other Listeria spp. 
in milk, is still extremely limited, bearing in mind, the detection 
of  these microorganisms in milk is not regulated by the Código 
Alimentario Argentino [27]. To our knowledge, the only previous 
work carried out in our country to determine the presence of  
Listeria spp. in raw milk was reported by Laciar et al. [28]. These 
authors isolated L. monocytogenes, L. innocua and L. welshimeri. Con-
sidering that Argentina is an important producer of  milk world-
wide, the detection of  listerial species, such as the one carried out 
in this work, shows that it is essential to search for these bacteria 
in milk in order to ensure its safety.
In this work, we report the in vitro antimicrobial activity of  two 
probiotic and bacteriocinogenic strains, L. fermentum L23 and L. 
rhamnosus L60, on a total of  29 listerial strains (27 strains of  L. 
monocytogenes isolated from food and clinical samples, and L. in-
nocua LI1 and L. welshimeri LW1 recovered from raw cow milk). 
The streak diffusion method performed served as a preliminary 
technique for screening of  listerial susceptibility to antimicrobi-
al substances produced by these lactobacilli strains. The results 
showed that lactobacilli inhibited 100% of  the tested Listeria spp. 
(data not shown). The inhibition zone produced by L. fermentum 
L23 showed a mean value of  20.64 ± 4.92 mm, whereas that of  
L. rhamnosus L60 was of  19.67 ± 4.94 mm. There was no statis-
tical difference between these inhibition values (P<0.05). These 
results showed that both Lactobacillus strains had a strong biologi-
cal activity to inhibit the listerial growth. Previous studies have 
demonstrated the antimicrobial power of  different lactobacilli 
strains against certain species of  Listeria spp. [29]. Nevertheless, 
in comparison with our work, L. fermentum L23 and L. rhamnosus 
L60 proved to have a wider range of  antilisterial activity because 
they inhibited all Listeria spp. tested, independently from where 
they were originally isolated.
The antilisterial activity of  the CFS and NCFS containing the 
BLIS-es, L23 or L60, from L. fermentum L23  or L. rhamnosus L60, 
respectively, was tested by the well diffusion method. The mean 
inhibition halos obtained on each listerial strain are shown in table 
1. Results showed that both CFS containing all the substances 
with antimicrobial activity inhibited all the tested Listeria spp. The 
mean inhibition halos produced by the CFS of  L. fermentum L23 
and L. rhamnosus L60 on Listeria spp. were 21.10 ± 1.94 and 21.08 
± 2.35, respectively. There was no statistical difference between 
these inhibition values (P<0.05). After treatment with NaOH 1 
mol ml-1, both NCFS maintained a high antimicrobial activity on 
listerial growth. The mean inhibition halos produced by the NCFS 
of  L. fermentum L23 and L. rhamnosus L60 on listerial growth were 
17.90 ± 1.74 mm and 17.73 ± 1.93 mm, respectively. Antimicrobi-
al activities found with each NCFS against Listeria spp. growth did 
not show significant differences (P<0.05). The higher percentage 
of  antilisterial activity remained in the NCFSs of  both lactobacilli 
strains. In the case of  L. fermentum L23 this biological activity was 
due to the BLIS L23 while for L. rhamnosus L60, the NCFS con-
tains the BLIS L60 as well as hydrogen peroxide. Our research 
group have previously demonstrated that hydrogen peroxide pro-
duced by L. rhamnosus L60 had a weak antimicrobial activity on 
a wide variety of  bacterial genera [13, 15, 21]. On this regards, 
it was assumed that the antimicrobial effect of  both NCFSs was 
due to the BLIS-es L23 and L60, which were the metabolites re-
sponsible of  the main antilisterial effect. Indeed, both bacterioc-
ins inhibited the growth of  100% of  Listeria spp. Only in the case 
of  L. monocytogenes, similar results were found by Altuntas et al. 
[11], who demonstrated the susceptibility of  those strains to the 
non-treated CFS containing a bacteriocin produced by Pediococcus 
spp. In a similar study, Vera Pingitore et al. [30] studied the anti-
microbial activity of  two NCFS containing different bacteriocins 
and found different levels of  resistance among L. monocytogenes, 
L. innocua, L. welshimeri and L. seeligeri strains. Furthermore, Dortu 
et al. [31] reported a high sakacin G resistance level (40%) for L. 
monocytogenes strains. At this point, our findings demonstrate the 
relevant antilisterial activity of  these two bacteriocins based on 
both, the large number of  susceptible strains and the high sizes 
of  inhibition halos produced by them.
The proportion of  antimicrobial effect of  the main biometabo-
lites was estimated based on the sizes of  inhibition halos pro-
duced by CFS and NCFS of  each Lactobacillus strain. The aver-
age sizes of  inhibition zones produced by CFS and NCFS of  L. 
fermentum L23 strain were significantly different (P<0.05), due to 
the joint action of  organic acid and the BLIS L23, in comparison 
with the inhibition found by the BLIS alone. Thus, the propor-
tion of  biological activity on Listeria spp. produced by BLIS L23 
and organic acids were 85% and 15%, respectively. The same dif-
ferences were observed between CFS and NCFS of  L. rhamnosus 
L60. In this case, 84% of  inhibition was mainly attributed to BLIS 
L60 and 16% to organic acids.
Table 2 shows the MIC values of  BLIS-es L23 or L60 on all Lis-
teria spp. MICs of  both BLIS-es ranged between 40 and 160 AU 
ml-1 for all strains tested of  Listeria spp. The BLIS L23 inhibited 
the growth of  19 strains of  L. monocytogenes (70.37%) with a very 
low MIC value. In the case of  the BLIS L60, 23 strains of  L. 
monocytogenes (85.18%) were inhibited with MIC values ranged be-
tween 40-80 AU ml-1. On the other hand, both BLIS-es showed 
the same MIC value to inhibit the growth of  L. innocua LI1 and 
L. welshimeri LW1. The low MIC values for each BLIS, in com-
parison with their maximum activity (640 AU ml-1), showed that 
even when they are highly diluted, they remained active against 
all Listeria spp. tested. These results differed from those by Kaur 
et al. [32], who evaluated pediocin 34 and enterocin FH99, whose 
MIC values were higher in comparison with the reported here 
for L23 and L60. These findings could serve as an biotechnologi-
cal advantage for the development of  novel products, potentially 
useful, to minimize the presence of  Listeria spp. in food industry.
Conclusion
This study demonstrated that Listeria species contaminated raw 
cow milk in an important milking area of  Argentina. In addition, 
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Table 1. Antimicrobial activity of  non-treated and treated cell free supernatants of  Lactobacillus fermentum L23 and       
Lactobacillus rhamnosus L60 on the growth of  different Listeria spp.
Listeria spp.
Mean of  inhibition halo in mm (mean ± SD)
Lactobacillus fermentum L23 Lactobacillus rhamnosus L60
CFS NCFS CFS NCFS
L. monocytogenes LM1 23.75±2.50a 20.00±2.45a 21.00±4.18a 20.33±3.01a
L. monocytogenes LM2 23.00±1.00a 18.00±0.00b 25.00±2.00a 18.67±1.15b
L. monocytogenes LM3 19.33±1.15a 17.75±1.26a 20.00±1.00a 17.33±1.53a
L. monocytogenes LM4 19.60±3.58a 18.00±2.83a 18.00±1.82a 17.67±0.58a
L. monocytogenes LM5 19.33±1.53a 15.00±1.00b 20.00±1.73a 16.67±1.15a
L. monocytogenes LM6 22.50±3.56a 20.83±1.04a 21.67±0.58a 21.00±2.64a
L. monocytogenes LM7 21.33±0.58a 19.67±0.58b 19.00±1.00a 16.00±1.00b
L. monocytogenes LM8 23.17±1.33a 20.00±1.87b 24.50±1.22a 20.60±1.34b
L. monocytogenes LM9 22.33±0.58a 19.00±0.00b 20.00±0.00a 17.67±1.53a
L. monocytogenes LM11 20.80±2.68a 16.20±1.64b 19.30±0.67a 16.60±1.14b
L. monocytogenes LM12 19.67±0.58a 15.00±1.00b 21.00±2.65a 16.33±0.58b
L. monocytogenes LM14 25.67±0.58a 19.67±0.58b 27.67±0.58a 19.00±1.00b
L. monocytogenes LM15 21.00±1.00a 17.67±1.15b 20.67±1.53a 18.33±1.53a
L. monocytogenes LM16 20.50±3.70a 18.67±1.15a 17.25±0.95a 17.00±0.00a
L. monocytogenes LM17 23.67±2.31a 17.75±3.86a 19.50±1.80a 18.50±0.71a
L. monocytogenes LM18 21.00±2.16a 20.00±1.00a 21.50±3.11a 15.57±0.58b
L. monocytogenes LM19 18.00±0.00a 17.00±1.41a 21.20±1.09a 19.00±0.82b
L. monocytogenes LM20 21.67±2.31a 20.00±1.00a 22.33±0.58a 18.33±0.58b
L. monocytogenes LM21 23.33±1.53a 17.67±0.58b 24.33±0.58a 21.67±1.53b
L. monocytogenes LM22 19.33±0.58a 19.00±1.00a 22.50±2.38a 18.67±1.15a
L. monocytogenes LM23 19.67±1.37a 15.75±2.22b 22.40±1.95a 18.00±1.00b
L. monocytogenes LM24 20.13±6.00a 15.17±5.00b 18.60±4.27a 14.00±2.34a
L. monocytogenes LM25 24.00±1.73a 18.33±0.58b 24.00±0.00a 18.67±1.15b
L. monocytogenes LM26 21.67±1.53a 18.00±1.00b 20.33±0.51a 14.67±0.58b
L. monocytogenes LM30 21.00±1.00a 19.00±1.00a 19.00±1.00a 17.33±0.58a
L. monocytogenes LM31 19.33±0.58a 16.67±0.58b 20.33±1.15a 18.00±2.00a
L. monocytogenes LM32 20.00±1.15a 18.67±1.53a 22.00±0.00a 19.33±0.58b
L. innocua LI1 17.67±1.15a 15.00±1.41b 20.00±1.00a 14.75±0.50b
L. welshimeri LW1 19.33±0.58a 15.67±1.15b 18.33±0.58a 15.33±0.58b
Total mean ± SD 21.10 ± 1.94a 17.90 ± 1.74b 21.08 ± 2.35a 17.76 ± 1.91b
References: CFS: cell free supernatant, NCFS: cell free supernatant neutralized with NaOH 1 mol ml-1. Inhibition halos with different 
letters indicate significant difference between CFS and NCFS of  each lactobacilli strains (P< 0.05).
Table 2. Minimum inhibitory concentrations of  bacteriocin like inhibitory substances L23 and L60 produced by probiotic 
lactobacilli on all susceptible strains of  Listeria spp.
Susceptible Listeria spp. (n=29) MIC (AU ml-1) % sensitive strains
BLIS L23 BLIS L60
L. monocytogenes 
160
80
40
11.11
18.52
70.37
14.82
40.74
44.44
L. innocua 160 100 100
L. welshimeri 160 100 100
References: BLIS: Bacteriocin-like inhibitory substance; MIC: Minimum inhibitory concentration; AU-1 ml: Activity units per milliliter
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L. fermentum L23 and L. rhamnosus L60 proved to have meaning-
ful antimicrobial activity on all of  the tested listerial strains. This 
antilisterial effect was mainly due to bacteriocins L23 and L60, 
which were still active at very low concentrations. These findings 
are promising as a biological strategy to prevent or reduce the risk 
of  acquiring severe infections by the main pathogen, L. monocy-
togenes, through food transmission to human. Future studies shall 
be needed to evaluate the application of  these bacteriocin produc-
ing strains in milk and/or dairy food.
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